RhoBTB2 (DBC2) functions as a multifunctional tumor suppressor in thyroid cancer cells via mitochondrial apoptotic pathway

Thyroid cancer is the most common endocrine malignancy worldwide. Tumor suppressor gene RhoBTB2 (also known as Deleted in Breast Cancer 2, DBC2) was observed in various carcinomas, however, no reports showed the effects of RhoBTB2 on thyroid cancer. In our study, we found that RhoBTB2 decreases prol...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical and experimental medicine 2015-01, Vol.8 (4), p.5954-5958
Main Authors: Wang, Chuan-Jiang, Yang, Dong, Luo, Ying-Wei
Format: Article
Language:English
Subjects:
Original
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 5958
container_issue 4
container_start_page 5954
container_title International journal of clinical and experimental medicine
container_volume 8
creator Wang, Chuan-Jiang
Yang, Dong
Luo, Ying-Wei
description Thyroid cancer is the most common endocrine malignancy worldwide. Tumor suppressor gene RhoBTB2 (also known as Deleted in Breast Cancer 2, DBC2) was observed in various carcinomas, however, no reports showed the effects of RhoBTB2 on thyroid cancer. In our study, we found that RhoBTB2 decreases proliferation, increases apoptosis, inhibits mobility, and induces mitochondria damage in SW579 cells through increased Bax and decreased Bcl-2 and Bcl-xL protein expression. The effects of RhoBTB2 on SW579 cells were inversed by using butin (an inhibitor of the mitochondrial apoptosis pathway). Our results suggest that RhoBTB2 suppresses the growth of SW579 cells through a mitochondrial apoptosis pathway.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4483867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1693188026</sourcerecordid><originalsourceid>FETCH-LOGICAL-p266t-f5a988758c87ab92ae8dd0f3e08134da13fc9ee954f7f2345e9b8f30450af4df3</originalsourceid><addsrcrecordid>eNpVUF1LAzEQPESxtfoXJI_14SBfd01eBFs_oSBIfT7SXOJF7pKY5Cr113tiKxUWdpjdmWH3KBsjTmFecIiOD_AoO4vxHcISYcJPsxEuEUGIo3H29dK4-WqOwfR2vsBXQPdWJuNsBGIo0PVtMntOtCD1nQsg9t4HFeMAjQWp2QZnaiCFlSoAqdo2go0ZxCY52ThbBzNIhXc-uWQk8CI1n2J7np1o0UZ1seuT7PX-brV4zJfPD0-Lm2XucVmmXBeCMzYrmGQzseZYKFbXUBMFGSK0FohoyZXiBdUzjQktFF8zTSAtoNC01mSSXf_6-n7dqVoqm4JoKx9MJ8K2csJU_yfWNNWb21SUMsLK2WAw3RkE99GrmKrOxJ8zhVWujxUqOUGMQVwOq5eHWX8h-4eTb6xEgPw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1693188026</pqid></control><display><type>article</type><title>RhoBTB2 (DBC2) functions as a multifunctional tumor suppressor in thyroid cancer cells via mitochondrial apoptotic pathway</title><source>PubMed Central</source><creator>Wang, Chuan-Jiang ; Yang, Dong ; Luo, Ying-Wei</creator><creatorcontrib>Wang, Chuan-Jiang ; Yang, Dong ; Luo, Ying-Wei</creatorcontrib><description>Thyroid cancer is the most common endocrine malignancy worldwide. Tumor suppressor gene RhoBTB2 (also known as Deleted in Breast Cancer 2, DBC2) was observed in various carcinomas, however, no reports showed the effects of RhoBTB2 on thyroid cancer. In our study, we found that RhoBTB2 decreases proliferation, increases apoptosis, inhibits mobility, and induces mitochondria damage in SW579 cells through increased Bax and decreased Bcl-2 and Bcl-xL protein expression. The effects of RhoBTB2 on SW579 cells were inversed by using butin (an inhibitor of the mitochondrial apoptosis pathway). Our results suggest that RhoBTB2 suppresses the growth of SW579 cells through a mitochondrial apoptosis pathway.</description><identifier>ISSN: 1940-5901</identifier><identifier>EISSN: 1940-5901</identifier><identifier>PMID: 26131191</identifier><language>eng</language><publisher>United States: e-Century Publishing Corporation</publisher><subject>Original</subject><ispartof>International journal of clinical and experimental medicine, 2015-01, Vol.8 (4), p.5954-5958</ispartof><rights>IJCEM Copyright © 2015 2015</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483867/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483867/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26131191$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Chuan-Jiang</creatorcontrib><creatorcontrib>Yang, Dong</creatorcontrib><creatorcontrib>Luo, Ying-Wei</creatorcontrib><title>RhoBTB2 (DBC2) functions as a multifunctional tumor suppressor in thyroid cancer cells via mitochondrial apoptotic pathway</title><title>International journal of clinical and experimental medicine</title><addtitle>Int J Clin Exp Med</addtitle><description>Thyroid cancer is the most common endocrine malignancy worldwide. Tumor suppressor gene RhoBTB2 (also known as Deleted in Breast Cancer 2, DBC2) was observed in various carcinomas, however, no reports showed the effects of RhoBTB2 on thyroid cancer. In our study, we found that RhoBTB2 decreases proliferation, increases apoptosis, inhibits mobility, and induces mitochondria damage in SW579 cells through increased Bax and decreased Bcl-2 and Bcl-xL protein expression. The effects of RhoBTB2 on SW579 cells were inversed by using butin (an inhibitor of the mitochondrial apoptosis pathway). Our results suggest that RhoBTB2 suppresses the growth of SW579 cells through a mitochondrial apoptosis pathway.</description><subject>Original</subject><issn>1940-5901</issn><issn>1940-5901</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVUF1LAzEQPESxtfoXJI_14SBfd01eBFs_oSBIfT7SXOJF7pKY5Cr113tiKxUWdpjdmWH3KBsjTmFecIiOD_AoO4vxHcISYcJPsxEuEUGIo3H29dK4-WqOwfR2vsBXQPdWJuNsBGIo0PVtMntOtCD1nQsg9t4HFeMAjQWp2QZnaiCFlSoAqdo2go0ZxCY52ThbBzNIhXc-uWQk8CI1n2J7np1o0UZ1seuT7PX-brV4zJfPD0-Lm2XucVmmXBeCMzYrmGQzseZYKFbXUBMFGSK0FohoyZXiBdUzjQktFF8zTSAtoNC01mSSXf_6-n7dqVoqm4JoKx9MJ8K2csJU_yfWNNWb21SUMsLK2WAw3RkE99GrmKrOxJ8zhVWujxUqOUGMQVwOq5eHWX8h-4eTb6xEgPw</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Wang, Chuan-Jiang</creator><creator>Yang, Dong</creator><creator>Luo, Ying-Wei</creator><general>e-Century Publishing Corporation</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>RhoBTB2 (DBC2) functions as a multifunctional tumor suppressor in thyroid cancer cells via mitochondrial apoptotic pathway</title><author>Wang, Chuan-Jiang ; Yang, Dong ; Luo, Ying-Wei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p266t-f5a988758c87ab92ae8dd0f3e08134da13fc9ee954f7f2345e9b8f30450af4df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Wang, Chuan-Jiang</creatorcontrib><creatorcontrib>Yang, Dong</creatorcontrib><creatorcontrib>Luo, Ying-Wei</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of clinical and experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Chuan-Jiang</au><au>Yang, Dong</au><au>Luo, Ying-Wei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RhoBTB2 (DBC2) functions as a multifunctional tumor suppressor in thyroid cancer cells via mitochondrial apoptotic pathway</atitle><jtitle>International journal of clinical and experimental medicine</jtitle><addtitle>Int J Clin Exp Med</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>8</volume><issue>4</issue><spage>5954</spage><epage>5958</epage><pages>5954-5958</pages><issn>1940-5901</issn><eissn>1940-5901</eissn><abstract>Thyroid cancer is the most common endocrine malignancy worldwide. Tumor suppressor gene RhoBTB2 (also known as Deleted in Breast Cancer 2, DBC2) was observed in various carcinomas, however, no reports showed the effects of RhoBTB2 on thyroid cancer. In our study, we found that RhoBTB2 decreases proliferation, increases apoptosis, inhibits mobility, and induces mitochondria damage in SW579 cells through increased Bax and decreased Bcl-2 and Bcl-xL protein expression. The effects of RhoBTB2 on SW579 cells were inversed by using butin (an inhibitor of the mitochondrial apoptosis pathway). Our results suggest that RhoBTB2 suppresses the growth of SW579 cells through a mitochondrial apoptosis pathway.</abstract><cop>United States</cop><pub>e-Century Publishing Corporation</pub><pmid>26131191</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1940-5901
ispartof International journal of clinical and experimental medicine, 2015-01, Vol.8 (4), p.5954-5958
issn 1940-5901
1940-5901
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4483867
source PubMed Central
subjects Original
title RhoBTB2 (DBC2) functions as a multifunctional tumor suppressor in thyroid cancer cells via mitochondrial apoptotic pathway
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T16%3A18%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RhoBTB2%20(DBC2)%20functions%20as%20a%20multifunctional%20tumor%20suppressor%20in%20thyroid%20cancer%20cells%20via%20mitochondrial%20apoptotic%20pathway&rft.jtitle=International%20journal%20of%20clinical%20and%20experimental%20medicine&rft.au=Wang,%20Chuan-Jiang&rft.date=2015-01-01&rft.volume=8&rft.issue=4&rft.spage=5954&rft.epage=5958&rft.pages=5954-5958&rft.issn=1940-5901&rft.eissn=1940-5901&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1693188026%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p266t-f5a988758c87ab92ae8dd0f3e08134da13fc9ee954f7f2345e9b8f30450af4df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1693188026&rft_id=info:pmid/26131191&rfr_iscdi=true